Research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of ...

Long Covid remains a major concern for millions worldwide. After an infection caused by the SARS-CoV-2 virus, many ...

University of Arizona researchers are leading a national study to investigate and treat sleep issues linked to long COVID, ...

Three children were rescued from a COVID lockdown house of horrors after being forced for years to stay inside and wear face ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Groundbreaking research from the University of Virginia School of Medicine has revealed crucial new insights into the immune ...

While estimates of those still coping with Long COVID vary, some 20 million Americans have been diagnosed with Long Covid, ...

With over 65 million people suffering globally, US scientists have begun a major clinical trial to test a monoclonal antibody ...

A point prevalence survey of long-term care facilities in 18 European countries found 3.1% of residents had at least one ...

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...

The explanation for this treatment involves the cholinergic nervous system. The German scientists point out that SARS-CoV-2 ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...